VAERS Reports UJ600AAB

VAERS 2517282

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AAB

gering

Staat: NY
Alter: 3,0
Geschlecht: M
Eingang: 26.11.2022
Impfdatum: 17.11.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

child patient received ACTHIB vaccine about an hour ago that was expired with no reported adverse event; Initial information received on 17-Nov-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 3 years old male child patient who received acthib vaccine about an hour ago that was expired with no reported adverse event while receiving vaccine hib (prp/t) vaccine [Act-Hib]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Nov-2022, the patient received a dose 4 suspect hib (prp/t) vaccine Powder and solvent for solution for injection at a dose of 0.5 ml units total ( lot UJ600AAB) (expiry date: unknown) via intramuscular route in the left thigh for Immunization. On an unknown date the patient was diagnosed with non-serious event of "child patient received acthib vaccine about an hour ago that was expired with no reported adverse event" (expired product administered) (unknown latency) following the administration of hib (prp/t) vaccine. Action taken was not applicable. Outcome was Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2509263

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AAB

gering

Staat: NY
Alter: 0,5
Geschlecht: M
Eingang: 16.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

administered an expired ACT-HIB to a 6-month-old patient with no reported adverse event; Initial information received on 07-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old male patient whom had was administered with an expired haemophilus type B (HIB) Vaccine [ACT-HIB] to a 6-month-old patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Ipol polio vaccine [Polio vaccine inact 3v (vero)] On 27-Oct-2022, the patient received a dose of suspect haemophilus type B (HIB) Vaccine Powder and solvent for solution for injection dose 0.5 ml lot UJ600AAB, expiry date: 20-Oct-2022 via intramuscular route in the right thigh for immunization, the patient had administered an expired act-hib to a 6-month-old patient with no reported adverse event (expired product administered) on the same day Action taken was not applicable. At time of reporting, the outcome was Unknown for the event administered an expired act-hib to a 6-month-old patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2506580

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AAB

gering

Staat: NC
Alter: 1,0
Geschlecht: F
Eingang: 12.11.2022
Impfdatum: 02.11.2022
Beginn: 02.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

patient took expired ACTHIB vaccine, with no reported adverse event; Initial information received on 04-Nov-2022 regarding an unsolicited valid non-serious case received from a other healthcare professional. This case is linked to case 2022SA460139. This case involves a 1 years old female patient who took expired vaccine HIB (PRP/T) VACCINE [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL); and INFLUENZA VACCINE (INFLUENZA) for Immunisation. On 02-Nov-2022, the patient received 0.5 ml dose of suspect HIB (PRP/T) VACCINE (Powder and solvent for solution for injection) (lot UJ600AAB and expiry date: 29-Oct-2022) via intramuscular route in the left thigh for Immunization. On 02-Nov-2022 (latency: same day), the patient took expired HIB (PRP/T) VACCINE, with no reported adverse event (expired product administered). It was reported that "A nurse looked at the actual powder component which expires on 30Nov2022. This was realized after the injection." Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505322

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AAB

gering

Staat: NC
Alter: 1,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Medication error No adverse event

Symptomtext

given an expired ACTHIB vaccine,with no reported adverse event; Initial information received on 04-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old female patient who was given an expired acthib (HIB (PRP/T) VACCINE) vaccine,with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Immunisation; PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVENAR) for Immunisation; and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Immunisation. On 03-Nov-2022, the patient received a first dose of 0.5 ml of suspect HIB (PRP/T) VACCINE (formulation, strength: unknown) lot UJ600AAB, expiration date: 29-Oct-2022 via intramuscular route in the left thigh as Immunization On 03-NOV-2022 the patient was given an expired acthib vaccine,with no reported adverse event (expired product administered) same day following the administration of HIB (PRP/T) VACCINE. A nurse looked at the actual powder component which expires on 30Nov2022. This was realized after the injection. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (given an expired ACTHIB vaccine,with no reported adverse event). At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: MMR; PREVENAR; VARICELLA VACCINE
Allergien: -
Vorherige Impfungen: -

VAERS 2502866

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AAB

gering

Staat: -
Alter: 3,0
Geschlecht: M
Eingang: 09.11.2022
Impfdatum: 31.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

received an expired dose of ACT-HIB with no reported adverse event; Initial information received on 31-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 3 years old male patient who received an expired dose of hib (prp/t) vaccine [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 7v (crm197) (Prevnar) for Immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Daptacel) for Immunisation; and hepatitis a vaccine (Hepatitis A) for Immunisation. On 31-Oct-2022, the patient received a dose 4 of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection (strength: standard) 0.5mL (milliliter) total once (lot: UJ600AAB, expiry date: 29-Oct-2022) via intramuscular route in the thigh nos (not otherwise specified) for immunization. On 31-OCT-2022 the patient received an expired dose of act-hib with no reported adverse event (expired product administered) same day following the administration of vaccine. No lab data reported. Action taken was not applicable. Treatment- will be repeated. At time of reporting, the outcome was Unknown for the event

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -